Does combined Inactivation of MYC and K-Ras oncogenes reverse tumorigenesis in lung adenocarcinomas and lymphomas?
Taken together, our findings point to the importance of the K-Ras and associated down-stream Stat effector pathways in the initiation and maintenance of lymphomas and lung tumors. We suggest that combined targeting of oncogenic pathways is more likely to be effective in the treatment of lung cancers and lymphomas.
Significant indirect neural decompression is possible in XLIF, regardless of the presence of metabolically active FA.